Thinkstock
Industryweek 9600 Heart Drugs T

US Investigates Valeant over Drug Pricing

Oct. 15, 2015
Several Democratic lawmakers in late September had pressed Valeant to provide documentation explaining the spike in its prices early this year on two drugs used for cardiac care.

WASHINGTON - Canadian pharmaceutical group Valeant says it has received subpoenas from U.S. federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more affordable for patients.

Valeant (IW 1000/510) said Wednesday it intends to cooperate with the authorities, which also want the company to provide details on information it gave to the Centers for Medicare and Medicaid Services,

Several Democratic lawmakers in late September had pressed Valeant to provide documentation explaining the spike in its prices early this year on two drugs used for cardiac care.

Valeant is said to have increased the prices of Nitropress and Isuprel, by 525% and 212%, respectively, after purchasing the drugs.

The lawmakers, who have been investigating Valeant for several weeks, are also seeking to have chief executive Michael Pearson testify.

"All of us at Valeant firmly believe in maintaining strong regulatory and financial controls and believe we have operated our business in a fully compliant manner," Pearson said in a statement. 

"We remain committed to assisting eligible patients who need our products, and we will be working with the appropriate groups to submit the requested documents and plan to cooperate with the inquiries."

Copyright Agence France-Presse, 2015

Popular Sponsored Recommendations

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Smarter Savings for Manufacturers - Guide

Sept. 12, 2023
Enhance your service experiences and boost revenue while reducing costs. Learn how one platform can help your business be more agile and productive in today's market.

Powering Up Productivity: The Transformative Power of AP Automation in Manufacturing

Oct. 25, 2023
Discover how AP Automation is revolutionizing the manufacturing industry, driving efficiency, cost savings, and security. In today's world, automation is the key to staying competitive...

You Cannot Stay Competitive by Bolting New Technologies to a Legacy ERP

Oct. 20, 2023
Read this white paper to understand the benefits of shifting to a next-generation ERP system as part of a DOP.

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!